These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2140871)

  • 1. Naloxone and its use in neonatal septic shock.
    Nash PL
    Neonatal Netw; 1990 Jun; 8(6):29-34. PubMed ID: 2140871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of naloxone in treating endotoxic shock.
    Schumann LL; Remington MA
    Crit Care Nurse; 1990 Feb; 10(2):63-73. PubMed ID: 2357885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Naloxone and endotoxic shock: a wonder drug?].
    Valdivielso A; Casado Flores J; Ruiz Beltrán A; García Pérez J; García-Onieva M; Hidalgo I
    An Esp Pediatr; 1984 Feb; 20(2):85-90. PubMed ID: 6712029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.
    Faden AI; Holaday JW
    J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of naloxone on endotoxic and hemorrhagic shock in horses.
    Weld JM; Kamerling SG; Combie JD; Nugent TE; Woods WE; Oeltgen P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):227-38. PubMed ID: 6739953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Naloxone hydrochloride in the therapy of endotoxic shock following meningococcal disease. Initial results].
    Martinón JM; Franco A; García JL; Fuster M; Bao A; Martinón F; Peña J
    An Esp Pediatr; 1982 Dec; 17(6):457-60. PubMed ID: 7183216
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose naloxone: pharmacokinetics in patients in septic shock.
    Groeger JS; Inturrisi CE
    Crit Care Med; 1987 Aug; 15(8):751-6. PubMed ID: 3608532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock.
    Dziki AJ; Lynch WH; Ramsey CB; Law WR
    Circ Shock; 1993 Jan; 39(1):29-38. PubMed ID: 8386986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effects of naloxone hydrochloride and methiodide on endotoxic shock in the anesthetized rat].
    Rios L; Jacob J
    Arch Inst Pasteur Tunis; 1981; 58(3):313-27. PubMed ID: 7316611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone in the refractory neonatal septic shock.
    Radicioni M; Mezzetti D
    Minerva Pediatr; 2013 Feb; 65(1):122-3. PubMed ID: 23422583
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of naloxone on endotoxin-induced pulmonary platelet sequestration.
    Almqvist P; Kuenzig M; Schwartz SI
    Acta Chir Scand; 1983; 149(1):23-6. PubMed ID: 6340398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of naloxone in septic shock.
    Canady J; Williams W; Thompson I; Vincent GS; Hoover E
    J Natl Med Assoc; 1989 Jun; 81(6):669-73. PubMed ID: 2746688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma beta-endorphin-like-immunoreactivity levels and hemodynamics in patients with septic shock.
    Hughes GS
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):121-31. PubMed ID: 3158042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systems.
    Holaday JW; Faden AI
    Adv Biochem Psychopharmacol; 1981; 28():421-34. PubMed ID: 7211552
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of the effect of the administration of naloxone in comparison with methylprednisolone in infants with septic shock].
    Véliz-Pintos RA; Torres-Bedoya MA; Forero-Gómez J; Olvera-Hidalgo C; Orozco-Veráztegui O
    Bol Med Hosp Infant Mex; 1985 Sep; 42(9):531-40. PubMed ID: 4063047
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of vasoactive mediator antagonists on endotoxic shock in dogs. I.
    Toth PD; Hamburger SA; Judy WV
    Circ Shock; 1984; 12(4):277-86. PubMed ID: 6722995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naloxone therapy on hemodynamics and metabolism following a superlethal dosage of Escherichia coli endotoxin in dogs.
    Raymond RM; Harkema JM; Stoffs WV; Emerson TE
    Surg Gynecol Obstet; 1981 Feb; 152(2):159-62. PubMed ID: 6782687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen.
    Almqvist PM; Ekström B; Kuenzig M; Haglund U; Schwartz SI
    Circ Shock; 1984; 14(2):129-36. PubMed ID: 6509725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone therapy of human septic shock.
    Bonnet F; Bilaine J; Lhoste F; Mankikian B; Kerdelhue B; Rapin M
    Crit Care Med; 1985 Nov; 13(11):972-5. PubMed ID: 2932301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.